OpenVSafe by OpenVAERS
Search V-safe

FWK-19551-94792

5 vaccinations 28 coded responses 63 check-ins 28 free-text entries 0 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
017 / MA
Registered
2021-01-27
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-27
    Registered in v-safe
  2. 2021-01-27
    Dose 1 — Moderna
  3. 2021-01-27
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: Musculoskeletal stiffness — Feeling: Good · Site: Pain, Swelling
    Free text: Shoulder(inj site side) upper back and neck stiffness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-29
    Survey response — days 1–6 daily, dose 1
    MedDRA: Influenza like illness — Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness, Nausea
    Free text: Flu-like feeling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-30
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dermatitis, Rash papular — Feeling: Good · Site: Swelling · Rash, not including the immediate area around the injection site
    Free text: Raised rash on chin. Looks like dermatitis.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-03
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-02-10
    Survey response — day 14, dose 1
    MedDRA: Arthralgia, Injection site pain, Injection site pruritus, Injection site rash, Injection site swelling, Rash papular — Feeling: Good
    Free text: Itching at inj site on Day 8. Immediate raised, red rash 3x 4, after scratching. W/in 10 min, swelling and soreness at inj site same as Day 1. Shoulder soreness developed that night lasting 4 days. Itch/swell again on Day 9. Rash for 4 days
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-17
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-02-24
    Dose 2 — Moderna
  14. 2021-02-24
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Decreased appetite, Dizziness — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Free text: Dizziness, lack of appetite
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-26
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chills, Pyrexia — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Be unable to do your normal daily activities
    Free text: Yesterday afternoon after I submitted my check-in, I developed a fever of 101.5 and chills which lasted about 4 hours, cycling between fever and chills.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness, Itching · None
    Adult check-in
  18. 2021-02-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Heart rate decreased — Feeling: Good · Site: Redness
    Free text: Sleeping heart rate measured by Apple Watch is approx 10bpm (53-58bpm, avg 56bpm) below normal for past two days. Same for road cycling and tennis.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Heart rate decreased — Feeling: Good
    Free text: Sleeping heart rate measured by Apple Watch lower than avg at 59bpm. (56-63bpm range)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-03-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Heart rate decreased — Feeling: Good
    Free text: Sleeping HR still low, avg 57bpm (54-61)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-03-05
    Survey response — day 7, dose 2
    MedDRA: Unevaluable event — Feeling: Good
    Free text: Sleeping HR still 3-4 bpm lower than normal. Tennis and cycling HR 10-15bpm lower than normal
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-03-10
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-19
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-24
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-02
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-07
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-05-26
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-08-25
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-11-04
    Dose 3 — Moderna
  30. 2021-11-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness, Fatigue — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Dizziness, Fatigue
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-11-06
    Survey response — days 1–6 daily, dose 3
    MedDRA: Body temperature increased — Feeling: Good · Site: Pain, Redness, Swelling, Itching
    Free text: Fever was still at 99.8deg at 9pm yesterday. Normal temp is 97.2-97.6
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-11-07
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness — Feeling: Good · Site: Pain, Itching
    Free text: Dizziness
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-11-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Itching · None
    Adult check-in
  34. 2021-11-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-11-13
    Survey response — day 7, dose 3
    MedDRA: No adverse event — Feeling: Good
    Free text: No
    MedDRA releases: 2024-11 · check-in free text available
  36. 2021-11-18
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-11-25
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-12-02
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-12-09
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-12-16
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-02-03
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-05-05
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  43. 2022-05-13
    Dose 4 — Moderna
  44. 2022-05-14
    Survey response — days 1–6 daily, dose 4
    MedDRA: Dyspnoea — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Shortness of breath
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-05-15
    Survey response — days 1–6 daily, dose 4
    MedDRA: Tinnitus — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Tinnitus
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-05-16
    Survey response — days 1–6 daily, dose 4
    MedDRA: Heart rate increased — Feeling: Good · Site: Pain
    Free text: High heart rate
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-05-17
    Survey response — days 1–6 daily, dose 4
    MedDRA: Heart rate increased, Tinnitus — Feeling: Good
    Free text: High resting heart rate (20%+) and tinnitus
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-05-18
    Survey response — days 1–6 daily, dose 4
    MedDRA: Heart rate increased, Tinnitus — Feeling: Good
    Free text: Tinnitus, High resting heart rate (20%+)
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-05-19
    Survey response — days 1–6 daily, dose 4
    MedDRA: Heart rate increased, Tinnitus — Feeling: Good
    Free text: Tinnitus and elevated resting heart rate (20%+)
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-05-20
    Survey response — day 7, dose 4
    MedDRA: Tinnitus, Unevaluable event — Feeling: Good
    Free text: Tinnitus, resting heart rate 15%+ normal
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-05-27
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  52. 2022-06-03
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  53. 2022-06-10
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  54. 2022-06-19
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  55. 2022-06-24
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  56. 2022-08-12
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  57. 2022-10-04
    Dose 5 — Moderna
  58. 2022-10-05
    Survey response — days 1–6 daily, dose 5
    MedDRA: Heart rate increased, Tinnitus — Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Free text: Tinnitus, elevated resting heart rate10-15% higher than normal
    MedDRA releases: 2024-11 · check-in free text available
  59. 2022-10-07
    Survey response — days 1–6 daily, dose 5
    MedDRA: Heart rate increased, Tinnitus — Feeling: Good
    Free text: Elevated resting heart rate15-20% higher than normal, tinnitus
    MedDRA releases: 2024-11 · check-in free text available
  60. 2022-10-08
    Survey response — days 1–6 daily, dose 5
    MedDRA: Heart rate increased — Feeling: Good
    Free text: Resting heart rate, is not about 10% above normal
    MedDRA releases: 2024-11 · check-in free text available
  61. 2022-10-09
    Survey response — days 1–6 daily, dose 5
    MedDRA: Heart rate increased — Feeling: Good
    Free text: Resting HR 15% above normal
    MedDRA releases: 2024-11 · check-in free text available
  62. 2022-10-13
    Survey response — day 7, dose 5
    MedDRA: Heart rate increased — Feeling: Good
    Free text: Resting heart rate still 10-15% above normal
    MedDRA releases: 2024-11 · check-in free text available
  63. 2022-10-18
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  64. 2022-10-25
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  65. 2022-11-01
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  66. 2022-11-08
    Survey response — day 35, dose 5
    MedDRA: Fatigue — Feeling: Good · Be unable to do your normal daily activities
    Free text: Fatigue
    MedDRA releases: 2024-11 · check-in free text available
  67. 2022-11-15
    Survey response — day 42, dose 5
    MedDRA: Fatigue — Feeling: Good · Be unable to do your normal daily activities
    Free text: Fatigue
    MedDRA releases: 2024-11 · check-in free text available
  68. 2023-01-09
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  69. 2023-04-04
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-27Moderna
22021-02-24Moderna
32021-11-04Moderna No
42022-05-13Moderna No
52022-10-04Moderna No

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-28

Systemic reaction (other): Shoulder(inj site side) upper back and neck stiffness

Release 3 — days 1–6 daily, dose 1

2021-01-29

Systemic reaction (other): Flu-like feeling

2021-01-30

Systemic reaction (other): Raised rash on chin. Looks like dermatitis.

Release 4 — day 14, dose 1

2021-02-10

Symptoms: Itching at inj site on Day 8. Immediate raised, red rash 3x 4, after scratching. W/in 10 min, swelling and soreness at inj site same as Day 1. Shoulder soreness developed that night lasting 4 days. Itch/swell again on Day 9. Rash for 4 days

Release 4 — days 1–6 daily, dose 2

2021-02-25

Systemic reaction (other): Dizziness, lack of appetite

2021-02-26

Systemic reaction (other): Yesterday afternoon after I submitted my check-in, I developed a fever of 101.5 and chills which lasted about 4 hours, cycling between fever and chills.

2021-02-28

Systemic reaction (other): Sleeping heart rate measured by Apple Watch is approx 10bpm (53-58bpm, avg 56bpm) below normal for past two days. Same for road cycling and tennis.

2021-03-01

Systemic reaction (other): Sleeping heart rate measured by Apple Watch lower than avg at 59bpm. (56-63bpm range)

2021-03-02

Systemic reaction (other): Sleeping HR still low, avg 57bpm (54-61)

Release 5 — day 7, dose 2

2021-03-05

Systemic reaction (other): Sleeping HR still 3-4 bpm lower than normal. Tennis and cycling HR 10-15bpm lower than normal

Release 10 — days 1–6 daily, dose 3

2021-11-05

Systemic reaction (other): Dizziness, Fatigue

2021-11-06

Systemic reaction (other): Fever was still at 99.8deg at 9pm yesterday. Normal temp is 97.2-97.6

2021-11-07

Systemic reaction (other): Dizziness

Release 10 — day 7, dose 3

2021-11-13

Systemic reaction (other): No

Release 11 — days 1–6 daily, dose 4

2022-05-14

Systemic reaction (other): Shortness of breath

2022-05-15

Systemic reaction (other): Tinnitus

2022-05-16

Systemic reaction (other): High heart rate

2022-05-17

Systemic reaction (other): High resting heart rate (20%+) and tinnitus

2022-05-18

Systemic reaction (other): Tinnitus, High resting heart rate (20%+)

2022-05-19

Systemic reaction (other): Tinnitus and elevated resting heart rate (20%+)

Release 11 — day 7, dose 4

2022-05-20

Systemic reaction (other): Tinnitus, resting heart rate 15%+ normal

Release 12 — days 1–6 daily, dose 5

2022-10-05

Systemic reaction (other): Tinnitus, elevated resting heart rate10-15% higher than normal

2022-10-07

Systemic reaction (other): Elevated resting heart rate15-20% higher than normal, tinnitus

2022-10-08

Systemic reaction (other): Resting heart rate, is not about 10% above normal

2022-10-09

Systemic reaction (other): Resting HR 15% above normal

Release 12 — day 7, dose 5

2022-10-13

Systemic reaction (other): Resting heart rate still 10-15% above normal

Release 12 — day 35, dose 5

2022-11-08

Symptoms: Fatigue

Release 12 — day 42, dose 5

2022-11-15

Symptoms: Fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDFatigue · · ✓
SDInjection site pain ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDInjection site rash ✓ ✓ ✓
SDInjection site swelling ✓ ✓ ✓
SDRash papular ✓ ✓ ✓
SROBody temperature increased · · ✓
SROChills ✓ ✓ ✓
SRODecreased appetite ✓ ✓ ✓
SRODermatitis ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SRODyspnoea · · ✓
SROFatigue · · ✓
SROHeart rate decreased ✓ ✓ ✓
SROHeart rate increased · · ✓
SROInfluenza like illness ✓ ✓ ✓
SROMusculoskeletal stiffness ✓ ✓ ✓
SRONo adverse event · · ✓
SROPyrexia ✓ ✓ ✓
SRORash papular ✓ ✓ ✓
SROTinnitus · · ✓
SROUnevaluable event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release